Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing and preventing acute urinary retention.

Herbert Lepor

    Reviews in Urology
    |September 21, 2006
    PubMed
    Summary
    This summary is machine-generated.

    Acute urinary retention (AUR) is a serious condition often affecting men with benign prostatic hyperplasia. Medications like alpha-blockers and 5-alpha-reductase inhibitors can help prevent AUR episodes in at-risk individuals.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Focal Cryo-Ablation for Treatment of Intermediate Favorable Risk (Grade Group 2) Prostate Cancer.

    Urology·2026
    Same author

    Indigo Carmine Visualization Duration in Urine: A Randomized Kinetics Study.

    Urogynecology (Philadelphia, Pa.)·2026
    Same author

    How urology can embrace the patient-centric precision focal therapy approach for localized prostate cancer.

    Nature reviews. Urology·2026
    Same author

    Magnetic Resonance Imaging-Directed Stereotactic Body Radiation Therapy Microboost in Concert With Pelvic Nodal Irradiation for Prostate Cancer in the Higher-Risk Spectrum: Toxicity.

    Advances in radiation oncology·2026
    Same author

    Evaluating indeterminate bone lesions and lymph nodes on PSMA-PET: a multidisciplinary consensus algorithm and 1-year implementation results.

    European radiology·2026
    Same author

    MRI performance to identify clinically significant prostate cancer following focal cryo-ablation.

    BJUI compass·2025

    Area of Science:

    • Urology
    • Geriatric Medicine
    • Pharmacology

    Background:

    • Acute urinary retention (AUR) is a common and potentially dangerous condition, particularly in men with benign prostatic hyperplasia (BPH).
    • Various triggers, including medications, infections, anesthesia, and urogenital procedures, can precipitate AUR episodes.
    • Catheterization, while effective for immediate relief, carries risks, making prevention a priority for high-risk individuals.

    Purpose of the Study:

    • To review the known precipitating factors for AUR in men with BPH.
    • To evaluate the efficacy of pharmacological interventions in preventing AUR episodes.
    • To identify strategies for reducing the incidence of AUR and the need for catheterization.

    Main Methods:

    • Literature review of studies investigating AUR triggers and prevention strategies.

    Related Experiment Videos

  • Analysis of clinical trial data on the use of alpha-blockers and 5-alpha-reductase inhibitors for AUR prevention.
  • Synthesis of evidence regarding the impact of these medications on AUR incidence.

    • Main Results:

    • Alpha-blockers and 5-alpha-reductase inhibitors have demonstrated effectiveness in reducing the occurrence of initial and recurrent AUR episodes.
    • These medications offer a viable strategy to mitigate the risks associated with catheterization in at-risk patient populations.
    • Understanding precipitating factors allows for targeted preventative measures.

    Conclusions:

    • Pharmacological interventions, specifically alpha-blockers and 5-alpha-reductase inhibitors, are effective in preventing acute urinary retention in men with BPH.
    • Preventative strategies can reduce the need for catheterization and its associated complications.
    • Further research may explore optimal drug combinations and patient selection for AUR prevention.